Looking for a product? Use our Product Finder instead.
INOVYN to expand General Purpose PVC production at Jemeppe Site, Belgium
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
Since acquiring the Forties Pipeline System (FPS) in November 2017, we have, and continue, to invest heavily in environmental improvements to deliver our ambitious plans for a sustainable future.
In order to ensure a fair market as referred to in article 9b paragraph 1 of the Decree on the Supervision of the Securities Trade 1995 (the “Decree”), Hawkslease Finance Company Limited ("Hawkslease") makes the following announcement. On 12 December 2002 Hawkslease announced the intention to mak
An integrated trading business focusing on Gas, Power, Carbon and Group Advisory Services
In order to ensure a fair market as referred to in article 9b of the Decree on the Supervision of the Securities Trade 1995, Hawkslease Finance Company Limited (“HFCL”) makes the following announcement. On 12 December 2002 HFCL announced its intention to make a cash Offer (the “Offer”) for all ou
Our focus in the manufacturing and delivery of these products is on quality, reliability of service and on-time delivery in support of our customers’ winning strategies.
INEOS continues to make steady progress towards the safe repair of the Forties Pipeline. Continued monitoring and assessment confirms that the hairline crack has remained stable since the flow of oil and gas was stopped through the pipe on Monday 11th December. Work on the pipeline is progressing
We pride ourselves on our ability to proactively and flexibly respond to customer needs.
INEOS Group Holdings PLC (‘INEOS’ or ‘Group’) is providing an update on liquidity and trading in the fourth quarter of 2008. Based on unaudited preliminary management information, INEOS estimates that EBITDA adjusted to exclude inventory holding gains and losses (‘Replacement Cost’ or ‘RC’ EBITDA
671 - 680 of 1903 Results